pharma · Hypertension · Breast Neoplasms
Pfizer
Pfizer is a pharma organization headquartered in PARIS, FR. Primary therapeutic focus areas include Hypertension, Breast Neoplasms, Complicated Intra-abdominal Infection, Non-Small Cell Lung Cancer, Arthritis, Rheumatoid
New York 10017, US HQ
103,316 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- New York 10017, US
- Employees
- 103,316
- Programs
- 98
- Drugs
- 63
- Patents
- 0
PF-07275315 dose 1
Phase 3 · small molecule · Moderate to Severe Chronic Obstructive Pulmonary Disease
PF-07275315 dose 1 for Moderate to Severe Chronic Obstructive Pulmonary Disease is a Phase 3 program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Internal code C4531031
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Pfizer
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Moderate to Severe Chronic Obstructive Pulmonary Disease
- Status
- active
- Trials
- 1